Sentry Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$53.4M Sell
1,586,323
-1,052,103
-40% -$36.2M 0.8% 40
2017
Q4
$90.7M Sell
2,638,426
-302,866
-10% -$10.3M 1.15% 31
2017
Q3
$99.6M Buy
2,941,292
+58,497
+2% +$1.88M 1.01% 32
2017
Q2
$91.9M Buy
2,882,795
+2,277,061
+376% +$71.8M 0.67% 33
2017
Q1
$19.7M Buy
+605,734
New +$19.1M 0.14% 90

Other funds holding PFE

Sentry Investments's PFE Position: Q1 2018 in Review

Sentry Investments reduced its Pfizer (PFE) stake by 40% in Q1 2018, selling an estimated $36.2M and leaving 1,586,323 shares worth $53.4M. The position accounts for 0.8% of the portfolio, ranked #40.

Sentry Investments first reported a position in PFE in Q1 2017 and has held it in 5 quarters since. The position peaked at $99.6M in Q3 2017. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

  • Sentry Investments held 1,586,323 shares of Pfizer worth $53.4M as of Q1 2018.
  • Sentry Investments sold 1,052,103 Pfizer shares in Q1 2018, an estimated $36.2M.
  • Pfizer made up 0.8% of Sentry Investments's portfolio in Q1 2018, its #40 holding.
  • Sentry Investments first reported a position in Pfizer in Q1 2017 and has held it in 5 quarters since.
  • Sentry Investments's Pfizer position peaked at $99.6M in Q3 2017.
  • 2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Sentry Investments's 13F filing for Q1 2018, filed 11 May 2018.